Infinant Health

Our mission is to change the trajectory of human health, one baby at a time.

Sacramento, United States · Founded 2011 · $125.0M raised

Employees
11–50
Founded
2011
Business Model
B2B2C
Total Funding
$125.0M
Last Round
$55.0M Series DFeb 2021
Rounds
5

About

Infinant Health is a clinical-stage biotechnology company developing live biotherapeutic products focused on the infant gut microbiome. Its lead candidate, INF108, is a next-generation B. infantis drug strain designed to prevent necrotizing enterocolitis (NEC) in premature infants. The company's research builds on the relationship between breast milk, B. infantis, and early immune development to establish a healthier foundation for lifelong health.

Summary

Infinant Health is a Healthcare company based in Sacramento, United States, founded in 2011. It has raised $125.0M in total across 5 rounds, most recently a $55.0M Series D round in Feb 2021. Investors include Horizons Ventures, Cargill and Bill & Melinda Gates Foundation.

Tech & App Stack

7 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series DSeries DFeb 2021
$55.0M

Sign up to see all 5 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies